Literature DB >> 24436520

Combining locoregional therapies in the treatment of hepatocellular carcinoma.

Mikhail C S S Higgins1, Michael C Soulen1.   

Abstract

In an effort to promote more durable local control of larger lesions, thermal ablation has been combined with chemical ablative techniques and with vaso-occlusive procedures such as chemoembolization and bland embolization in an effort to mitigate the limitations inherent in the use of any single treatment for hepatocellular carcinoma (HCC) >3 cm. The heat-sink effect is the underlying principle for combining vaso-occlusive therapies with ablative techniques. Combination therapies do present viable options for abrogating tumor progression and potentially downsizing tumors to facilitate transplant. We discuss the two most commonly used combination locoregional therapies by the interventionalist and the evidence defining the best techniques in practice.

Entities:  

Keywords:  ablation; chemoembolization; combination therapy; hepatoma; interventional radiology

Year:  2013        PMID: 24436520      PMCID: PMC3700791          DOI: 10.1055/s-0033-1333656

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  57 in total

Review 1.  Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

Authors:  J-L Raoul; B Sangro; A Forner; V Mazzaferro; F Piscaglia; L Bolondi; R Lencioni
Journal:  Cancer Treat Rev       Date:  2010-08-17       Impact factor: 12.111

2.  Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection.

Authors:  K N Khan; H Yatsuhashi; K Yamasaki; M Yamasaki; O Inoue; M Koga; M Yano
Journal:  J Hepatol       Date:  2000-02       Impact factor: 25.083

3.  Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.

Authors:  Mary Maluccio; Anne M Covey; Ripal Gandhi; Mithat Gonen; George I Getrajdman; Lynn A Brody; Yuman Fong; William Jarnagin; Michael D'Angelica; Leslie Blumgart; Ronald DeMatteo; Karen T Brown
Journal:  J Vasc Interv Radiol       Date:  2005-07       Impact factor: 3.464

4.  A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

Authors:  Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Tomonori Fujishima; Takashi Ishikawa; Yukihiro Koike; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

5.  Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.

Authors:  H-X Xu; M-D Lu; X-Y Xie; X-Y Yin; M Kuang; J-W Chen; Z-F Xu; G-J Liu
Journal:  Clin Radiol       Date:  2005-09       Impact factor: 2.350

6.  Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

Authors:  Shi-Ming Lin; Chun-Jung Lin; Chen-Chun Lin; Chao-Wei Hsu; Yi-Cheng Chen
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

7.  Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.

Authors:  T Higuchi; M Kikuchi; M Okazaki
Journal:  Cancer       Date:  1994-05-01       Impact factor: 6.860

Review 8.  Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies.

Authors:  Yun Ku Cho; Jae Kyun Kim; Mi Young Kim; Hyunchul Rhim; Joon Koo Han
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

9.  Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

Authors:  T Livraghi; A Giorgio; G Marin; A Salmi; I de Sio; L Bolondi; M Pompili; F Brunello; S Lazzaroni; G Torzilli
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740

View more
  11 in total

1.  [Thermoablative therapy of hepatocellular carcinoma. Indications, technique and results].

Authors:  T Hofmockel; V Plodeck; M Laniado; R-T Hoffmann
Journal:  Radiologe       Date:  2014-07       Impact factor: 0.635

Review 2.  Microwave ablation in primary and secondary liver tumours: technical and clinical approaches.

Authors:  Maria Franca Meloni; Jason Chiang; Paul F Laeseke; Christoph F Dietrich; Angela Sannino; Marco Solbiati; Elisabetta Nocerino; Christopher L Brace; Fred T Lee
Journal:  Int J Hyperthermia       Date:  2016-08-02       Impact factor: 3.914

Review 3.  Current locoregional therapies and treatment strategies in hepatocellular carcinoma.

Authors:  L Cardarelli-Leite; A Hadjivassiliou; D Klass; J Chung; S G F Ho; H J Lim; P T W Kim; A Mujoomdar; D M Liu
Journal:  Curr Oncol       Date:  2020-11-01       Impact factor: 3.677

Review 4.  Management of "very early" hepatocellular carcinoma on cirrhotic patients.

Authors:  Gonzalo Sapisochin; Elena Fernandez de Sevilla; Juan Echeverri; Ramón Charco
Journal:  World J Hepatol       Date:  2014-11-27

5.  The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma.

Authors:  Wei Qiu; Guangyi Wang; Xiaodong Sun; Junfeng Ye; Feng Wei; Xiaoju Shi; Guoyue Lv
Journal:  Med Oncol       Date:  2015-02-20       Impact factor: 3.064

6.  Evaluation of the Heat Sink Effect After Transarterial Embolization When Performed in Combination with Thermal Ablation of the Liver in a Rabbit Model.

Authors:  Charles J Puza; Qi Wang; Charles Y Kim
Journal:  Cardiovasc Intervent Radiol       Date:  2018-07-23       Impact factor: 2.740

Review 7.  Treatment of Primary Liver Tumors and Liver Metastases, Part 2: Non-Nuclear Medicine Techniques.

Authors:  Francois H Cornelis; Stephen B Solomon
Journal:  J Nucl Med       Date:  2018-10-25       Impact factor: 10.057

8.  Non-invasive magnetic resonance-guided high intensity focused ultrasound ablation of a vascular malformation in the lower extremity: a case report.

Authors:  Johanna M M van Breugel; Robbert J Nijenhuis; Mario G Ries; Raechel J Toorop; Evert-Jan P A Vonken; Joost W Wijlemans; Maurice A A J van den Bosch
Journal:  J Ther Ultrasound       Date:  2015-12-30

9.  Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas.

Authors:  Tai-Yang Zuo; Feng-Yong Liu; Mao-Qiang Wang; Xian-Xian Chen
Journal:  Chin Med J (Engl)       Date:  2017-11-20       Impact factor: 2.628

10.  Long-term Outcomes of Transcatheter Arterial Chemoembolization Combined With Radiofrequency Ablation as an Initial Treatment for Early-Stage Hepatocellular Carcinoma.

Authors:  Yao Jun Zhang; Min Shan Chen; Yong Chen; Wan Yee Lau; Zhenwei Peng
Journal:  JAMA Netw Open       Date:  2021-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.